• Ellagic Acid: Precision Tool for CK2 Pathway and Cancer Rese

  2026-06-10

  Ellagic acid, a selective ATP-competitive CK2 inhibitor, is transforming cancer biology and oxidative stress assays by providing specificity and robust signaling pathway modulation. Discover optimized workflows, troubleshooting strategies, and the translational impact informed by recent machine learning-driven senolytic discovery.

• MDM1 Overexpression Enhances Chemoradiotherapy Sensitivity i

  2026-06-10

  This article analyzes recent findings showing that MDM1 overexpression in colorectal cancer (CRC) increases p53 expression and apoptosis, thereby enhancing chemoradiotherapy sensitivity. The study suggests that MDM1 may serve as a predictive biomarker for treatment response, and highlights how modulating apoptosis pathways can restore therapy sensitivity in resistant CRC models.

• AZD2461: Redefining PARP Inhibition and Drug Resistance in C

  2026-06-09

  This thought-leadership article explores how AZD2461, a novel PARP inhibitor, is transforming translational cancer research. By integrating mechanistic insights, in vitro validation strategies, and the most current evidence on overcoming Pgp-mediated resistance, the piece offers actionable guidance for researchers working on breast cancer, DNA repair pathways, and BRCA1-mutated tumor models. The discussion moves beyond typical product summaries, providing both competitive context and a visionary outlook for future therapeutic innovation.

• Amyloid β-Peptide (1-42): Microglial Clearance and Assay Pre

  2026-06-09

  Explore the pivotal role of Amyloid β-Peptide (1-42) in Alzheimer’s disease research, with a deep dive into microglial clearance mechanisms and advanced assay optimization. Uncover new insights for experimental design using this essential Aβ42 peptide.

• Applied Workflows with 4μ8C: Unfolded Protein Response Inhib

  2026-06-08

  4μ8C (7-hydroxy-4-methyl-2-oxochromene-8-carbaldehyde) enables precise, selective inhibition of IRE1α RNase activity for dissecting ER stress responses in cancer and immunometabolic models. This guide delivers actionable workflows, troubleshooting strategies, and protocol enhancements that empower researchers to achieve reproducible, pathway-specific results.

• Gly-Gly-Phe-Gly: Optimizing Linker Design in Drug Conjugatio

  2026-06-08

  Gly-Gly-Phe-Gly (GGFG) is a flexible peptide linker that enables high-precision drug conjugation and antibody-drug conjugate (ADC) development. This guide details experimental workflows, troubleshooting strategies, and practical insights for leveraging GGFG in advanced bioconjugation and peptide engineering.

• Metabolic Modulation Enhances Ferroptosis and Cuproptosis in

  2026-06-07

  The referenced study introduces a nanosystem-based metabolic intervention that sensitizes cancer cells to both ferroptosis and cuproptosis by targeting glycolysis and NAD+ metabolism. This dual activation not only amplifies regulated cell death but also remodels the tumor immune microenvironment, offering new directions for anti-tumor therapy.

• Azithromycin and Roxithromycin as Novel Senolytic Agents Tar

  2026-06-06

  Ozsvari et al. (2018) demonstrate that the clinically approved antibiotics azithromycin and roxithromycin selectively eliminate senescent human fibroblasts, defining a new class of senolytic drugs. This research provides a methodological framework for drug repurposing in cellular senescence and offers practical insight for aging research and senescent cell detection.

• Isradipine (Dynacirc): Beyond Hypertension—Precision in Calc

  2026-06-05

  Explore how Isradipine (Dynacirc) advances neuroprotective agent research through selective L-type calcium channel blockade. This article provides a deep comparative analysis and practical insights for assay optimization, setting it apart from existing resources.

• Machine Learning Uncovers New Senolytics for Cell Clearance

  2026-06-05

  This study pioneers the use of cost-effective machine learning to identify new senolytic compounds, offering a scalable strategy for selectively removing senescent cells implicated in aging and disease. The validated approach reduces screening costs and expands opportunities for drug discovery in age-related and degenerative conditions.

• Rotigotine Hydrochloride: Innovations in Neuroprotection and

  2026-06-04

  Explore the advanced neuroprotective actions and novel delivery strategies of Rotigotine hydrochloride, a potent dopamine D2/D3 receptor agonist, with in-depth analysis of nanoparticle-mediated brain targeting for Parkinson's disease research. This article offers new perspectives on translational assay design and practical workflow integration.

• HCN Channels Mediate Heart Rate Response to Temperature Chan

  2026-06-04

  Wu et al. uncover a conserved motif in HCN4 channels that mediates heart rate acceleration in response to heat, independent of cyclic nucleotide signaling. This finding clarifies the molecular mechanism linking temperature sensing to cardiac pacemaker function, with implications for understanding physiological adaptation and stress responses.

• N-MYC and eIF4G1: New Targets in inv(16) Acute Myeloid Leuke

  2026-06-03

  Peramangalam et al. uncover a novel oncogenic axis in inv(16) acute myeloid leukemia (AML), showing that N-MYC regulates leukemic survival through eIF4G1. The study demonstrates that targeting the CBFβ-SMMHC fusion protein with a selective inhibitor leads to downregulation of MYCN and impaired leukemia cell viability, offering new insights for translational AML research.

• DAMGO: Precision µ-Opioid Receptor Agonist in Pain Research

  2026-06-03

  DAMGO enables high-specificity probing of µ-opioid receptor signaling, helping researchers unravel opioid mechanisms and circumvent confounding receptor cross-activity. Its robust performance in both in vitro and in vivo assays makes it a cornerstone for advanced opioid receptor pharmacology studies.

• Capsaicin-Induced Autophagy Preserves BMSC Function Under St

  2026-06-02

  The reference study demonstrates that capsaicin protects bone marrow stromal cells (BMSCs) from oxidative stress by activating autophagy through TRPV1-mediated calcium influx and suppression of the PI3K/AKT/mTOR pathway. These findings offer mechanistic insight into potential strategies for enhancing BMSC survival and osteogenic capacity in osteoporosis.

450 records 15/30 page Previous Next First page 上5页 1112131415 下5页 Last page